首页 > 最新文献

Visceral Medicine最新文献

英文 中文
Appendicitis in Pregnancy: A Multidisciplinary Approach and Optimal Management from the Perspective of Gynecology and Obstetrics - A Case Report. 妊娠阑尾炎:从妇产科角度的多学科方法和最佳管理- 1例报告。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-01 Epub Date: 2024-12-30 DOI: 10.1159/000543297
Jan Zapletal, Borek Sehnal, Vit Drochytek, Martin Hruda, Ivana Lochmanova, Michael J Halaska, Martin Oliverius

Introduction: Appendectomy for acute appendicitis is the most common surgical procedure performed during pregnancy. The primary treatment for acute appendicitis is emergency surgery, which can be particularly challenging due to altered anatomical conditions. Preoperative and postoperative care may require certain examinations due to pregnancy that are not standard within surgical practice or may be overlooked by the attending gynecologist.

Case presentation: A patient at 31 weeks of gestation presented to the obstetric clinic with an acute onset of acute appendicitis. After completing all necessary examinations and a thorough multidisciplinary evaluation, a successful laparoscopic appendectomy was performed. The subsequent hospitalization was complicated by the onset of uterine contractions, for which tocolysis was administered in combination with corticosteroid therapy to induce fetal lung maturity.

Conclusion: In the presented case report, we demonstrate an example of the appropriate multidisciplinary approach with an analysis of the specific steps that should be taken to maximize the benefit for both the fetus and the mother, as well as the surgical team. In the discussion, we outline the steps that should be followed for patient benefit and forensic reasons.

导言急性阑尾炎的阑尾切除术是孕期最常见的外科手术。急性阑尾炎的主要治疗方法是急诊手术,由于解剖条件的改变,这种手术尤其具有挑战性。由于怀孕,术前和术后护理可能需要进行某些检查,而这些检查并非外科手术的标准检查,也可能被主治妇科医生忽视:一名妊娠 31 周的患者因急性阑尾炎急性发作来到产科门诊。在完成所有必要的检查和全面的多学科评估后,成功实施了腹腔镜阑尾切除术。随后的住院治疗因子宫收缩而变得复杂,为此,医生使用了催产素和皮质类固醇治疗,以促使胎儿肺部成熟:在本病例报告中,我们举例说明了适当的多学科方法,并分析了为使胎儿和母亲以及手术团队获得最大利益而应采取的具体步骤。在讨论中,我们概述了为患者利益和法医原因而应遵循的步骤。
{"title":"Appendicitis in Pregnancy: A Multidisciplinary Approach and Optimal Management from the Perspective of Gynecology and Obstetrics - A Case Report.","authors":"Jan Zapletal, Borek Sehnal, Vit Drochytek, Martin Hruda, Ivana Lochmanova, Michael J Halaska, Martin Oliverius","doi":"10.1159/000543297","DOIUrl":"10.1159/000543297","url":null,"abstract":"<p><strong>Introduction: </strong>Appendectomy for acute appendicitis is the most common surgical procedure performed during pregnancy. The primary treatment for acute appendicitis is emergency surgery, which can be particularly challenging due to altered anatomical conditions. Preoperative and postoperative care may require certain examinations due to pregnancy that are not standard within surgical practice or may be overlooked by the attending gynecologist.</p><p><strong>Case presentation: </strong>A patient at 31 weeks of gestation presented to the obstetric clinic with an acute onset of acute appendicitis. After completing all necessary examinations and a thorough multidisciplinary evaluation, a successful laparoscopic appendectomy was performed. The subsequent hospitalization was complicated by the onset of uterine contractions, for which tocolysis was administered in combination with corticosteroid therapy to induce fetal lung maturity.</p><p><strong>Conclusion: </strong>In the presented case report, we demonstrate an example of the appropriate multidisciplinary approach with an analysis of the specific steps that should be taken to maximize the benefit for both the fetus and the mother, as well as the surgical team. In the discussion, we outline the steps that should be followed for patient benefit and forensic reasons.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":"41 2","pages":"86-91"},"PeriodicalIF":1.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11975332/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143813145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pregnant Patients with Gastrointestinal Problems. 患有胃肠道疾病的孕妇。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-01 Epub Date: 2025-02-14 DOI: 10.1159/000544735
Thomas Wirth, Beate Rau
{"title":"Pregnant Patients with Gastrointestinal Problems.","authors":"Thomas Wirth, Beate Rau","doi":"10.1159/000544735","DOIUrl":"https://doi.org/10.1159/000544735","url":null,"abstract":"","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":"41 2","pages":"51-52"},"PeriodicalIF":1.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11975345/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143813169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Premature Exchange of Percutaneous Biliary Drainage in Benign and Malignant Biliary Strictures: A Retrospective Single-Center Study. 良性和恶性胆道狭窄患者过早行经皮胆道引流的危险因素:一项回顾性单中心研究。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-03-28 DOI: 10.1159/000545420
Alica Kubesch, Alexander Schütz, Georg Dultz, Fabian Finkelmeier, Natalie Filmann, Jörg Bojunga, Stefan Zeuzem, Mireen Friedrich-Rust, Dirk Walter

Introduction: Treating biliary obstruction remains a common clinical problem. Endoscopic retrograde cholangiopancreatography (ERCP) with stent insertion remains the gold standard. If ERCP fails, percutaneous transhepatic biliary drainage (PTBD) is one treatment option. Despite a high success rate, early- and late-onset complications occur frequently, ranging from 20 to 70%. With this study, we aimed to provide further insights on possible risk factors for PTBD-related complications.

Methods: All cases with PTBD placement at our institution over the past 13 years were retrospectively analyzed and median premature exchange rate as well as procedural-associated complications were determined.

Results: A total of 976 PTBDs were inserted in 194 patients. In 853 cases (87%), only one PTBD was inserted. Most patients had a benign disease as an indication for the PTBD insertion (n = 558 cases, 56.9%). A premature PTBD exchange occurred in 246 cases (26%). The most common reason for a premature PTBD exchange or extraction was dislocation (n = 98/39.5%), followed by cholangitis in 70 cases (28.6%). A malignant indication (multivariate p = 0.001 OR = 1.69 95% CI = 1.23-2.30), female sex (multivariate p < 0.001 OR = 2.21 95% CI = 1.56-3.12), and a PTBD ≥14Fr (multivariate p < 0.03 1.50 (1.04-2.11) were associated with a premature stent exchange in the mixed multivariate regression analysis.

Conclusion: Premature exchanges occur frequently in patients treated with PTBD. Especially in patients with malignancy, other interventional bile drainage interventions should be discussed. In case PTBD is chosen, earlier exchange rates than 12 weeks should be considered.

导言:治疗胆道梗阻仍然是一个常见的临床问题。内镜逆行胆管造影(ERCP)与支架置入仍然是金标准。如果ERCP失败,经皮经肝胆道引流(PTBD)是一种治疗选择。尽管成功率很高,但早发性和晚发性并发症经常发生,发生率从20%到70%不等。通过这项研究,我们旨在进一步了解ptsd相关并发症的可能危险因素。方法:回顾性分析我院13年来所有PTBD置换术病例,确定中位过早置换率及手术相关并发症。结果:194例患者共植入ptbd 976枚。853例(87%)中仅置入1例PTBD。大多数患者有良性疾病作为PTBD插入的指征(n = 558例,56.9%)。246例(26%)发生PTBD过早置换。早期PTBD置换或拔出最常见的原因是脱位(n = 98/39.5%),其次是胆管炎(70例)(28.6%)。在混合多因素回归分析中,恶性适应症(多因素p = 0.001 OR = 1.69 95% CI = 1.23-2.30)、女性(多因素p < 0.001 OR = 2.21 95% CI = 1.56-3.12)、PTBD≥14Fr(多因素p < 0.03 1.50(1.04-2.11))与支架置换术过早相关。结论:过早交换在PTBD患者中经常发生。尤其是恶性肿瘤患者,应探讨其他介入胆管引流干预措施。如果选择PTBD,则应考虑比12周更早的汇率。
{"title":"Risk Factors for Premature Exchange of Percutaneous Biliary Drainage in Benign and Malignant Biliary Strictures: A Retrospective Single-Center Study.","authors":"Alica Kubesch, Alexander Schütz, Georg Dultz, Fabian Finkelmeier, Natalie Filmann, Jörg Bojunga, Stefan Zeuzem, Mireen Friedrich-Rust, Dirk Walter","doi":"10.1159/000545420","DOIUrl":"https://doi.org/10.1159/000545420","url":null,"abstract":"<p><strong>Introduction: </strong>Treating biliary obstruction remains a common clinical problem. Endoscopic retrograde cholangiopancreatography (ERCP) with stent insertion remains the gold standard. If ERCP fails, percutaneous transhepatic biliary drainage (PTBD) is one treatment option. Despite a high success rate, early- and late-onset complications occur frequently, ranging from 20 to 70%. With this study, we aimed to provide further insights on possible risk factors for PTBD-related complications.</p><p><strong>Methods: </strong>All cases with PTBD placement at our institution over the past 13 years were retrospectively analyzed and median premature exchange rate as well as procedural-associated complications were determined.</p><p><strong>Results: </strong>A total of 976 PTBDs were inserted in 194 patients. In 853 cases (87%), only one PTBD was inserted. Most patients had a benign disease as an indication for the PTBD insertion (<i>n</i> = 558 cases, 56.9%). A premature PTBD exchange occurred in 246 cases (26%). The most common reason for a premature PTBD exchange or extraction was dislocation (<i>n</i> = 98/39.5%), followed by cholangitis in 70 cases (28.6%). A malignant indication (multivariate <i>p</i> = 0.001 OR = 1.69 95% CI = 1.23-2.30), female sex (multivariate <i>p</i> < 0.001 OR = 2.21 95% CI = 1.56-3.12), and a PTBD ≥14Fr (multivariate <i>p</i> < 0.03 1.50 (1.04-2.11) were associated with a premature stent exchange in the mixed multivariate regression analysis.</p><p><strong>Conclusion: </strong>Premature exchanges occur frequently in patients treated with PTBD. Especially in patients with malignancy, other interventional bile drainage interventions should be discussed. In case PTBD is chosen, earlier exchange rates than 12 weeks should be considered.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-6"},"PeriodicalIF":1.8,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074644/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144082337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Detection of Sporadic Pancreatic Cancer. 散发性胰腺癌的早期发现。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-03-28 DOI: 10.1159/000545424
Hans Scherübl, Roland Andersson, Daniel Ansari, Irene Esposito, Thilo Hackert, J-Matthias Löhr
{"title":"Early Detection of Sporadic Pancreatic Cancer.","authors":"Hans Scherübl, Roland Andersson, Daniel Ansari, Irene Esposito, Thilo Hackert, J-Matthias Löhr","doi":"10.1159/000545424","DOIUrl":"https://doi.org/10.1159/000545424","url":null,"abstract":"","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-4"},"PeriodicalIF":1.8,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074645/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144082333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Metastatic Colorectal Cancer in Pregnancy: A Systematic Review of a Multidisciplinary Challenge. 妊娠期转移性结直肠癌的管理:一项多学科挑战的系统综述。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-03-28 DOI: 10.1159/000545464
Florian Scholz, Teresa Starrach, Julian Holch, Volker Heinemann, Ulrich Wirth, Jens Werner, Florian Kühn
<p><strong>Background: </strong>The global incidence of colorectal cancer (CRC) in patients under 50 years of age, also referred to as "early-onset" CRC (EO-CRC), has increased significantly in recent decades. According to current projections, CRC is expected to become the leading cause of cancer-related deaths among individuals aged 20-49 by 2030. The American Cancer Society noted a significant rise in the proportion of CRC cases in adults under 55, increasing from 11% in 1995 to 20% by 2019. Furthermore, the incidence of EO-CRC is projected to surge by over 140% by 2030. At the same time, there has been a trend in industrialized countries towards a later age at first childbirth. In 2022, the mean age of women at the birth of their first child was over 30 years in seven EU Member States. Given those trends, an increase in gestational CRC diagnoses is anticipated, but the number of reports on the treatment of CRC during pregnancy is very limited.</p><p><strong>Aim: </strong>Due to bioethical concerns and the rarity of the condition, there is a lack of clinical studies and evidence-based guidelines. In this context, we conducted a literature review of the published case reports and series on patients diagnosed with metastatic CRC during pregnancy and complemented the results with an illustrative case from our institution. We aimed to summarize the current knowledge on the treatment of CRC during pregnancy and to advance the discussion on optimal therapeutic approaches in this complex clinical situation.</p><p><strong>Methods: </strong>A comprehensive literature review was conducted using PubMed, MEDLINE, and Embase to identify studies and case reports on metastatic CRC during pregnancy, focusing on therapeutic interventions and clinical outcomes. Articles published between 1990 and 2024 were screened; studies where treatment was initiated postpartum were excluded. Data on patient characteristics, treatment, and outcomes were extracted and synthesized narratively due to heterogeneity in study designs. An anonymized illustrative case was constructed from a retrospective analysis of patient records.</p><p><strong>Results: </strong>Our literature review identified 26 cases of metastatic CRC during pregnancy, reported in both case reports and case series. The primary symptoms at diagnosis were abdominal pain, constipation, and rectal bleeding. Most cases involved hepatic metastases, with some reports noting additional pulmonary, peritoneal, or ovarian spread. Chemotherapy, including FOLFOX and FOLFIRI regimens, was administered in many cases during pregnancy, with mixed outcomes. Several reports documented normal child development and maternal survival, while others noted adverse outcomes such as stillbirth, small-for-gestational-age infants, and maternal mortality. Surgical intervention was performed in select cases, with varying maternal and fetal outcomes.</p><p><strong>Conclusion: </strong>Although data on the treatment of metastatic CRC during pre
背景:全球50岁以下患者的结直肠癌(CRC)发病率,也被称为“早发性”CRC (EO-CRC),近几十年来显著增加。根据目前的预测,到2030年,结直肠癌预计将成为20-49岁人群癌症相关死亡的主要原因。美国癌症协会指出,55岁以下成年人患结直肠癌的比例显著上升,从1995年的11%上升到2019年的20%。此外,到2030年,EO-CRC的发病率预计将激增140%以上。与此同时,工业化国家出现了推迟初次生育年龄的趋势。2022年,欧盟7个成员国女性生第一个孩子的平均年龄超过30岁。鉴于这些趋势,预计妊娠期结直肠癌的诊断会增加,但关于妊娠期结直肠癌治疗的报告数量非常有限。目的:由于生物伦理问题和罕见的条件,缺乏临床研究和循证指南。在此背景下,我们对已发表的关于妊娠期诊断为转移性结直肠癌患者的病例报告和系列进行了文献回顾,并以我们机构的一个说明性病例作为补充。我们旨在总结目前关于妊娠期结直肠癌治疗的知识,并在这种复杂的临床情况下推进最佳治疗方法的讨论。方法:通过PubMed、MEDLINE和Embase进行文献综述,识别妊娠期转移性结直肠癌的研究和病例报告,重点关注治疗干预和临床结果。对1990年至2024年间发表的文章进行了筛选;排除了产后开始治疗的研究。由于研究设计的异质性,对患者特征、治疗和结果的数据进行了提取和叙述性综合。通过对患者记录的回顾性分析,构建了一个匿名的说明性病例。结果:我们的文献回顾确定了26例妊娠期转移性结直肠癌,在病例报告和病例系列中均有报道。诊断时的主要症状为腹痛、便秘和直肠出血。大多数病例涉及肝转移,也有一些报告指出肺、腹膜或卵巢转移。化疗,包括FOLFOX和FOLFIRI方案,在许多怀孕期间进行,结果不一。一些报告记录了正常的儿童发育和产妇存活率,而另一些报告则指出了诸如死胎、胎龄小的婴儿和产妇死亡率等不良后果。手术干预进行了选择的情况下,不同的产妇和胎儿的结局。结论:尽管关于妊娠期转移性结直肠癌治疗的数据有限,但必须考虑化疗和放疗辅助手术的疗效,以及胎儿毒性的可能性。这篇文献综述和我们的案例说明,一个适应的,但基于指南的治疗是可行的,这取决于临床情况。这种复杂病例的治疗应该是多学科的,并在有能力有效管理这些病例的专门中心进行。这种协作方法可以确保母亲和孩子的最佳结果,即使在转移性疾病阶段。
{"title":"Management of Metastatic Colorectal Cancer in Pregnancy: A Systematic Review of a Multidisciplinary Challenge.","authors":"Florian Scholz, Teresa Starrach, Julian Holch, Volker Heinemann, Ulrich Wirth, Jens Werner, Florian Kühn","doi":"10.1159/000545464","DOIUrl":"10.1159/000545464","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The global incidence of colorectal cancer (CRC) in patients under 50 years of age, also referred to as \"early-onset\" CRC (EO-CRC), has increased significantly in recent decades. According to current projections, CRC is expected to become the leading cause of cancer-related deaths among individuals aged 20-49 by 2030. The American Cancer Society noted a significant rise in the proportion of CRC cases in adults under 55, increasing from 11% in 1995 to 20% by 2019. Furthermore, the incidence of EO-CRC is projected to surge by over 140% by 2030. At the same time, there has been a trend in industrialized countries towards a later age at first childbirth. In 2022, the mean age of women at the birth of their first child was over 30 years in seven EU Member States. Given those trends, an increase in gestational CRC diagnoses is anticipated, but the number of reports on the treatment of CRC during pregnancy is very limited.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aim: &lt;/strong&gt;Due to bioethical concerns and the rarity of the condition, there is a lack of clinical studies and evidence-based guidelines. In this context, we conducted a literature review of the published case reports and series on patients diagnosed with metastatic CRC during pregnancy and complemented the results with an illustrative case from our institution. We aimed to summarize the current knowledge on the treatment of CRC during pregnancy and to advance the discussion on optimal therapeutic approaches in this complex clinical situation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A comprehensive literature review was conducted using PubMed, MEDLINE, and Embase to identify studies and case reports on metastatic CRC during pregnancy, focusing on therapeutic interventions and clinical outcomes. Articles published between 1990 and 2024 were screened; studies where treatment was initiated postpartum were excluded. Data on patient characteristics, treatment, and outcomes were extracted and synthesized narratively due to heterogeneity in study designs. An anonymized illustrative case was constructed from a retrospective analysis of patient records.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Our literature review identified 26 cases of metastatic CRC during pregnancy, reported in both case reports and case series. The primary symptoms at diagnosis were abdominal pain, constipation, and rectal bleeding. Most cases involved hepatic metastases, with some reports noting additional pulmonary, peritoneal, or ovarian spread. Chemotherapy, including FOLFOX and FOLFIRI regimens, was administered in many cases during pregnancy, with mixed outcomes. Several reports documented normal child development and maternal survival, while others noted adverse outcomes such as stillbirth, small-for-gestational-age infants, and maternal mortality. Surgical intervention was performed in select cases, with varying maternal and fetal outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Although data on the treatment of metastatic CRC during pre","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-11"},"PeriodicalIF":1.8,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12088682/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144112781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Sequelae of SARS-CoV-2 Infection in Patients with Inflammatory Bowel Diseases Compared to Relatives with SARS-CoV-2 Infection without Inflammatory Bowel Disease and Inflammatory Bowel Disease Patients without SARS-CoV-2: Results of a Retrospective Case-Control Study. 炎症性肠病患者中SARS-CoV-2感染的长期后遗症与非炎症性肠病患者和非SARS-CoV-2炎症性肠病患者亲属的比较:回顾性病例-对照研究的结果
IF 1.6 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 Epub Date: 2024-10-29 DOI: 10.1159/000541602
Benedikt Bierbaum, Ulrike von Arnim, Renate Schmelz, Rosa Rosania, Jens Walldorf, Michael Bierbaum, Sven Geißler, Markus Hänßchen, Andreas Stallmach, Philipp Reuken, Niels Teich

Introduction: Long-term sequelae following acute SARS-CoV-2 infection appear to be common in patients with inflammatory bowel diseases (IBDs).

Methods: We examined the frequency and characteristics of post-COVID-symptoms in patients with IBD (IBD-COVID), comparing them to two control cohorts: infected household members of the IBD-COVID patients without IBD (CONT-COVID) and IBD patients without SARS-COV-2 infection (IBD-no-COVID). A questionnaire for the retrospective documentation of possible post-COVID-19 symptoms was distributed to patients and controls from eight referral centers.

Results: The 319 IBD-COVID, 108 CONT-COVID, and the 221 IBD-no-COVID patients were similar in terms of sex, age, and comorbidities. The occurrence and duration of fatigue in the IBD-COVID cohort correlated with IBD activity. Other complaints such as reduced cognitive performance (p < 0.05) and sleeping disorders (p < 0.05) were even more common in IBD-COVID patients. Persistent hematochezia (p < 0.001), abdominal pain (p < 0.005), diarrhea (p < 0.0001), and anal problems (p < 0.01) were more often in the IBD-COVID patients than in the CONT-COVID cohort. Furthermore, typical IBD-associated symptoms persist for a longer period after an infection. Frequency of post-COVID complaints is higher in IBD patients compared to controls. After infection, the number of outpatient consultations increased in IBD-COVID patients (7.8% vs. 10.9%, p = 0.008).

Conclusion: Fatigue, cognitive impairment, and sleep disturbances are more prevalent among IBD-COVID than CONT-COVID patients. Furthermore, typical IBD-associated symptoms persist for a longer period after an infection. Frequency of post-COVID complaints is higher in IBD patients compared to controls. Tight control of IBD activity could be a suitable tool to avoid post-COVID problems.

急性SARS-CoV-2感染后的长期后遗症似乎在炎症性肠病(IBDs)患者中很常见。方法:检测IBD患者(IBD- covid)的冠后症状发生频率和特征,并将其与未感染IBD的IBD- covid患者(con - covid)和未感染SARS-COV-2的IBD患者(IBD-no- covid)两组对照进行比较。向来自8个转诊中心的患者和对照组分发了一份问卷,用于回顾性记录可能的covid -19后症状。结果:319例IBD-COVID、108例con - covid和221例ibd - non - covid患者在性别、年龄和合并症方面相似。IBD- covid队列中疲劳的发生和持续时间与IBD活性相关。其他症状,如认知能力下降(p < 0.05)和睡眠障碍(p < 0.05)在IBD-COVID患者中更为常见。持续性便血(p < 0.001)、腹痛(p < 0.005)、腹泻(p < 0.0001)和肛门问题(p < 0.01)在IBD-COVID患者中比在con - covid队列中更常见。此外,典型的ibd相关症状在感染后持续较长时间。与对照组相比,IBD患者的covid后投诉频率更高。感染后,IBD-COVID患者的门诊就诊次数增加(7.8%比10.9%,p = 0.008)。结论:IBD-COVID患者的疲劳、认知障碍和睡眠障碍发生率高于con - covid患者。此外,典型的ibd相关症状在感染后持续较长时间。与对照组相比,IBD患者的covid后投诉频率更高。严格控制IBD活性可能是避免covid后问题的合适工具。
{"title":"Long-Term Sequelae of SARS-CoV-2 Infection in Patients with Inflammatory Bowel Diseases Compared to Relatives with SARS-CoV-2 Infection without Inflammatory Bowel Disease and Inflammatory Bowel Disease Patients without SARS-CoV-2: Results of a Retrospective Case-Control Study.","authors":"Benedikt Bierbaum, Ulrike von Arnim, Renate Schmelz, Rosa Rosania, Jens Walldorf, Michael Bierbaum, Sven Geißler, Markus Hänßchen, Andreas Stallmach, Philipp Reuken, Niels Teich","doi":"10.1159/000541602","DOIUrl":"10.1159/000541602","url":null,"abstract":"<p><strong>Introduction: </strong>Long-term sequelae following acute SARS-CoV-2 infection appear to be common in patients with inflammatory bowel diseases (IBDs).</p><p><strong>Methods: </strong>We examined the frequency and characteristics of post-COVID-symptoms in patients with IBD (IBD-COVID), comparing them to two control cohorts: infected household members of the IBD-COVID patients without IBD (CONT-COVID) and IBD patients without SARS-COV-2 infection (IBD-no-COVID). A questionnaire for the retrospective documentation of possible post-COVID-19 symptoms was distributed to patients and controls from eight referral centers.</p><p><strong>Results: </strong>The 319 IBD-COVID, 108 CONT-COVID, and the 221 IBD-no-COVID patients were similar in terms of sex, age, and comorbidities. The occurrence and duration of fatigue in the IBD-COVID cohort correlated with IBD activity. Other complaints such as reduced cognitive performance (<i>p</i> < 0.05) and sleeping disorders (<i>p</i> < 0.05) were even more common in IBD-COVID patients. Persistent hematochezia (<i>p</i> < 0.001), abdominal pain (<i>p</i> < 0.005), diarrhea (<i>p</i> < 0.0001), and anal problems (<i>p</i> < 0.01) were more often in the IBD-COVID patients than in the CONT-COVID cohort. Furthermore, typical IBD-associated symptoms persist for a longer period after an infection. Frequency of post-COVID complaints is higher in IBD patients compared to controls. After infection, the number of outpatient consultations increased in IBD-COVID patients (7.8% vs. 10.9%, <i>p</i> = 0.008).</p><p><strong>Conclusion: </strong>Fatigue, cognitive impairment, and sleep disturbances are more prevalent among IBD-COVID than CONT-COVID patients. Furthermore, typical IBD-associated symptoms persist for a longer period after an infection. Frequency of post-COVID complaints is higher in IBD patients compared to controls. Tight control of IBD activity could be a suitable tool to avoid post-COVID problems.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":"41 1","pages":"21-31"},"PeriodicalIF":1.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11801853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143384095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discrimination between Inflammatory and Fibrotic Activity in Crohn's Disease-Associated Ileal-Colonic Anastomotic Strictures by Combined Ga-68-FAPI-46 and F-18-FDG-PET/CT Imaging. Ga-68-FAPI-46和F-18-FDG-PET/CT联合成像对克罗恩病相关回肠-结肠吻合口狭窄炎症和纤维化活动的鉴别
IF 1.6 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 Epub Date: 2024-12-20 DOI: 10.1159/000542160
Michael Beck, Torsten Kuwert, Armin Atzinger, Maximilian Gerner, Arndt Hartmann, Marc Saake, Michael Uder, Markus Friedrich Neurath, Raja Atreya

Introduction: The development of an intestinal stricture in patients with Crohn's disease represents an important and frequent complication, reflecting the progressive nature of the disease. Depending on the inflammatory and fibrotic composition of the stricture, intensified medical therapy, interventional endoscopy, or surgical intervention is required. However, currently available diagnostic approaches can only assess the level of inflammation, but not the degree of fibrosis, limiting rational therapeutic management of Crohn's disease patients. Recently, prolyl endopeptidase fibroblast activating protein (FAP) has been functionally implicated in fibrotic tissue remodelling, indicating it as a promising target for detection of sites of fibrotic tissue remodelling. Thus, intestinal fibrosis might be visualized using Gallium-68 labelled inhibitors of FAP (FAPI). While F-18-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/CT is a standard diagnostic tool for visualizing inflammatory processes, we combined Ga-68-FAPI-46-PET/CT and F-18-FDG-PET/CT to differentiate predominantly fibrotic or inflammatory areas in Crohn's disease patients with ileo-colonic strictures.

Methods: In our study, we analysed three Crohn's disease patients with anastomotic ileo-colonic strictures who underwent both dynamic Ga-68-FAPI-46-PET/CT and static F-18-FDG-PET/CT imaging to assess the level of visualized fibrotic areas within the stricture and differentiate it from inflammatory ones. PET images were analysed both visually and quantitatively. Furthermore, conventional MR enterography and endoscopy were performed in parallel to correlate observed findings. Two of the included patients underwent surgery and the histological specimen were analysed for the level of inflammation and fibrosis, which results were similarly compared to the findings of the PET imaging procedures.

Results: Different uptake patterns of Ga-68-FAPI-46 could be observed in the anastomotic ileo-colonic strictures of the examined Crohn's disease patients, respectively. Immunohistochemical analyses demonstrated that there was a correlation between the level of Ga-68-FAPI-46 uptake and severity of fibrosis, while FDG uptake correlated with the inflammatory activity in the analysed strictures.

Discussion: The combination with F-18-FDG-PET/CT represents a promising imaging modality to distinguish inflammation from fibrosis and guide subsequent therapy in stricturing Crohn's disease patients, warranting further studies.

克罗恩病患者肠道狭窄的发展是一种重要且常见的并发症,反映了该疾病的进行性。根据狭窄的炎症和纤维化成分,需要加强药物治疗,介入内窥镜检查或手术干预。然而,目前可用的诊断方法只能评估炎症水平,而不能评估纤维化程度,限制了克罗恩病患者的合理治疗管理。最近,脯氨酸内肽酶成纤维细胞激活蛋白(FAP)在功能上与纤维化组织重构有关,表明它是检测纤维化组织重构位点的一个有希望的靶点。因此,可以使用镓-68标记的FAP抑制剂(FAPI)可视化肠纤维化。虽然f -18-氟脱氧葡萄糖(FDG)-正电子发射断层扫描(PET)/CT是观察炎症过程的标准诊断工具,但我们将Ga-68-FAPI-46-PET/CT和F-18-FDG-PET/CT结合起来,以区分克罗恩病伴回肠结肠狭窄患者的主要纤维化或炎症区域。方法:在本研究中,我们分析了3例伴有吻合口回肠-结肠狭窄的克罗恩病患者,他们同时进行了动态Ga-68-FAPI-46-PET/CT和静态F-18-FDG-PET/CT成像,以评估狭窄内可见纤维化区域的水平,并将其与炎症区区分。对PET图像进行视觉和定量分析。此外,常规磁共振肠造影和内窥镜检查并行进行,以关联观察到的结果。其中两名患者接受了手术,并对组织学标本进行了炎症和纤维化水平分析,其结果与PET成像程序的结果相似。结果:在克罗恩病患者的回肠-结肠吻合口狭窄处,Ga-68-FAPI-46分别有不同的摄取模式。免疫组织化学分析表明,Ga-68-FAPI-46摄取水平与纤维化严重程度之间存在相关性,而FDG摄取与所分析狭窄的炎症活性相关。讨论:联合F-18-FDG-PET/CT是一种很有前景的成像方式,可以区分炎症和纤维化,指导狭窄性克罗恩病患者的后续治疗,值得进一步研究。
{"title":"Discrimination between Inflammatory and Fibrotic Activity in Crohn's Disease-Associated Ileal-Colonic Anastomotic Strictures by Combined Ga-68-FAPI-46 and F-18-FDG-PET/CT Imaging.","authors":"Michael Beck, Torsten Kuwert, Armin Atzinger, Maximilian Gerner, Arndt Hartmann, Marc Saake, Michael Uder, Markus Friedrich Neurath, Raja Atreya","doi":"10.1159/000542160","DOIUrl":"10.1159/000542160","url":null,"abstract":"<p><strong>Introduction: </strong>The development of an intestinal stricture in patients with Crohn's disease represents an important and frequent complication, reflecting the progressive nature of the disease. Depending on the inflammatory and fibrotic composition of the stricture, intensified medical therapy, interventional endoscopy, or surgical intervention is required. However, currently available diagnostic approaches can only assess the level of inflammation, but not the degree of fibrosis, limiting rational therapeutic management of Crohn's disease patients. Recently, prolyl endopeptidase fibroblast activating protein (FAP) has been functionally implicated in fibrotic tissue remodelling, indicating it as a promising target for detection of sites of fibrotic tissue remodelling. Thus, intestinal fibrosis might be visualized using Gallium-68 labelled inhibitors of FAP (FAPI). While F-18-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/CT is a standard diagnostic tool for visualizing inflammatory processes, we combined Ga-68-FAPI-46-PET/CT and F-18-FDG-PET/CT to differentiate predominantly fibrotic or inflammatory areas in Crohn's disease patients with ileo-colonic strictures.</p><p><strong>Methods: </strong>In our study, we analysed three Crohn's disease patients with anastomotic ileo-colonic strictures who underwent both dynamic Ga-68-FAPI-46-PET/CT and static F-18-FDG-PET/CT imaging to assess the level of visualized fibrotic areas within the stricture and differentiate it from inflammatory ones. PET images were analysed both visually and quantitatively. Furthermore, conventional MR enterography and endoscopy were performed in parallel to correlate observed findings. Two of the included patients underwent surgery and the histological specimen were analysed for the level of inflammation and fibrosis, which results were similarly compared to the findings of the PET imaging procedures.</p><p><strong>Results: </strong>Different uptake patterns of Ga-68-FAPI-46 could be observed in the anastomotic ileo-colonic strictures of the examined Crohn's disease patients, respectively. Immunohistochemical analyses demonstrated that there was a correlation between the level of Ga-68-FAPI-46 uptake and severity of fibrosis, while FDG uptake correlated with the inflammatory activity in the analysed strictures.</p><p><strong>Discussion: </strong>The combination with F-18-FDG-PET/CT represents a promising imaging modality to distinguish inflammation from fibrosis and guide subsequent therapy in stricturing Crohn's disease patients, warranting further studies.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":"41 1","pages":"1-13"},"PeriodicalIF":1.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11801851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do Antibiotics Cause Inflammatory Bowel Disease? A Systematic Review and Meta-Analysis. 抗生素会导致炎症性肠病吗?系统回顾和荟萃分析。
IF 1.6 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 Epub Date: 2024-10-23 DOI: 10.1159/000541601
Ellen Scharf, Peter Schlattmann, Johannes Stallhofer, Andreas Stallmach

Introduction: Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), exhibits a multifactorial pathogenesis influenced by genetic and environmental factors. Antibiotic usage has been implicated in modifying the gut microbiome, potentially leading to dysbiosis and contributing to IBD risk. Despite existing literature, the relationship remains inconclusive. This meta-analysis aimed to evaluate the association between prior antibiotic use and the onset of IBD.

Methods: A systematic literature search in PubMed was conducted to identify studies exploring the link between antibiotic use and subsequent IBD diagnosis. Studies reporting CD, UC, or both as primary outcomes were included. The meta-analysis, performed according to PRISMA guidelines, summarized risk estimates, represented as odds ratios (ORs), and corresponding confidence intervals (CIs). Subgroup analyses involved the categorization of antibiotics and the determination of the minimum number of antibiotic therapy courses administered.

Results: Out of 722 publications, 31 studies comprising 102,103 individuals met eligibility criteria. The pooled OR for IBD in those with prior antibiotic exposure was 1.40 (95% CI: 1.25-1.56). Antibiotic use was associated with an increased risk of IBD (OR: 1.52, 95% CI: 1.19-1.94). Notably, this association was confined to CD (OR: 1.50, 95% CI: 1.27-1.77), while no significant association was observed with UC (OR: 1.21, 95% CI: 1.00-1.47). Risk augmentation for IBD correlated positively with the number of antibiotic courses (OR: 1.08, 95% CI: 1.05-1.12).

Conclusion: Previous antibiotic use is associated with the later development of CD. A positive dose-response effect was also observed. Against this background, antibiotics should be used rationally.

简介:炎症性肠病(IBD)包括克罗恩病(CD)和溃疡性结肠炎(UC),其发病机制受遗传和环境因素的影响。抗生素的使用与肠道微生物群的改变有关,可能导致生态失调并增加IBD的风险。尽管已有文献,但这种关系仍然没有定论。本荟萃分析旨在评估既往抗生素使用与IBD发病之间的关系。方法:在PubMed上进行系统的文献检索,以确定探索抗生素使用与随后的IBD诊断之间联系的研究。报告CD、UC或两者作为主要结局的研究被纳入。根据PRISMA指南进行的荟萃分析总结了风险估计,用比值比(ORs)和相应的置信区间(CIs)表示。亚组分析包括抗生素的分类和最小抗生素疗程的确定。结果:在722份出版物中,31项研究(102103人)符合入选标准。既往抗生素暴露者IBD的综合OR为1.40 (95% CI: 1.25-1.56)。抗生素使用与IBD风险增加相关(OR: 1.52, 95% CI: 1.19-1.94)。值得注意的是,这种关联仅限于CD (OR: 1.50, 95% CI: 1.27-1.77),而与UC没有显著关联(OR: 1.21, 95% CI: 1.00-1.47)。IBD的风险增加与抗生素疗程数呈正相关(OR: 1.08, 95% CI: 1.05-1.12)。结论:既往抗生素使用与CD的后期发展相关,也观察到正的剂量反应效应。在此背景下,应合理使用抗生素。
{"title":"Do Antibiotics Cause Inflammatory Bowel Disease? A Systematic Review and Meta-Analysis.","authors":"Ellen Scharf, Peter Schlattmann, Johannes Stallhofer, Andreas Stallmach","doi":"10.1159/000541601","DOIUrl":"10.1159/000541601","url":null,"abstract":"<p><strong>Introduction: </strong>Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), exhibits a multifactorial pathogenesis influenced by genetic and environmental factors. Antibiotic usage has been implicated in modifying the gut microbiome, potentially leading to dysbiosis and contributing to IBD risk. Despite existing literature, the relationship remains inconclusive. This meta-analysis aimed to evaluate the association between prior antibiotic use and the onset of IBD.</p><p><strong>Methods: </strong>A systematic literature search in PubMed was conducted to identify studies exploring the link between antibiotic use and subsequent IBD diagnosis. Studies reporting CD, UC, or both as primary outcomes were included. The meta-analysis, performed according to PRISMA guidelines, summarized risk estimates, represented as odds ratios (ORs), and corresponding confidence intervals (CIs). Subgroup analyses involved the categorization of antibiotics and the determination of the minimum number of antibiotic therapy courses administered.</p><p><strong>Results: </strong>Out of 722 publications, 31 studies comprising 102,103 individuals met eligibility criteria. The pooled OR for IBD in those with prior antibiotic exposure was 1.40 (95% CI: 1.25-1.56). Antibiotic use was associated with an increased risk of IBD (OR: 1.52, 95% CI: 1.19-1.94). Notably, this association was confined to CD (OR: 1.50, 95% CI: 1.27-1.77), while no significant association was observed with UC (OR: 1.21, 95% CI: 1.00-1.47). Risk augmentation for IBD correlated positively with the number of antibiotic courses (OR: 1.08, 95% CI: 1.05-1.12).</p><p><strong>Conclusion: </strong>Previous antibiotic use is associated with the later development of CD. A positive dose-response effect was also observed. Against this background, antibiotics should be used rationally.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":"41 1","pages":"32-47"},"PeriodicalIF":1.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11801854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A German's Perspective on the Way toward Ambulatory Laparoscopic Cholecystectomy: A Postoperative Questionnaire. 德国人对门诊腹腔镜胆囊切除术的看法:一份术后问卷。
IF 1.6 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 Epub Date: 2024-11-29 DOI: 10.1159/000541656
Paul Leonard Weber, Konstantin Schürheck, Kim C Wagner, Nadine Köhler, Wolfgang Hiller, Karl J Oldhafer

Introduction: Ambulatory surgeries are on the rise in recent years and can offer benefits to patients as well as healthcare providers. Laparoscopic cholecystectomy is one of the procedures commonly done in an ambulatory setting, in some European countries. This study aims to gather patients' perceptions towards ambulatory cholecystectomy after undergoing laparoscopic cholecystectomy in an inpatient setting.

Methods: A total of 300 patients from two different hospitals in Germany received a postoperative questionnaire aimed at evaluating their willingness to undergo an ambulatory surgery. Surgeries were performed between January 1, 2017, and July 11, 2018. Operation setting (acute vs. elective), ASA classification, length of hospital stay, age, sex, living situation and location (city vs. rural), as well as status of employment were documented.

Results: Overall, 23% of patients reported considering ambulatory laparoscopic cholecystectomy (ALC), while 77% rejected an ALC. Objections included fear of complications (69%), anticipated pain (65%), concerns about their living situation/home care (21%), other reasons (8%), nausea and vomiting (3.4%). Baseline characteristics of the participants provided no statistical significance on willingness to undergo ALC: acute versus elective (p = 0.22), ASA classification (p = 0.77), age ≥65 years versus <65 years (p = 0.60), gender (p = 0.07), living situation (p = 0.49), location (p = 0.15).

Conclusion: There is a willingness for ALC, albeit still limited. Chosen criteria did not show a significant association for positive perception of ALC.

简介:近年来,门诊手术呈上升趋势,可以为患者和医疗保健提供者提供好处。在一些欧洲国家,腹腔镜胆囊切除术是一种通常在门诊环境下进行的手术。本研究旨在收集住院患者在接受腹腔镜胆囊切除术后对门诊胆囊切除术的看法。方法:来自德国两家不同医院的300名患者接受了术后问卷调查,旨在评估他们接受门诊手术的意愿。手术于2017年1月1日至2018年7月11日期间进行。记录了手术环境(急性vs择期)、ASA分类、住院时间、年龄、性别、居住状况和地点(城市vs农村)以及就业状况。结果:总体而言,23%的患者报告考虑门诊腹腔镜胆囊切除术(ALC),而77%的患者拒绝了ALC。反对意见包括担心并发症(69%)、预期疼痛(65%)、担心生活状况/家庭护理(21%)、其他原因(8%)、恶心和呕吐(3.4%)。受试者的基线特征:急性与择期(p = 0.22)、ASA分类(p = 0.77)、年龄≥65岁对p = 0.60)、性别(p = 0.07)、生活状况(p = 0.49)、地点(p = 0.15)对接受ALC的意愿没有统计学意义。结论:尽管仍然有限,但仍有接受ALC的意愿。所选择的标准没有显示出对ALC的积极认知的显著关联。
{"title":"A German's Perspective on the Way toward Ambulatory Laparoscopic Cholecystectomy: A Postoperative Questionnaire.","authors":"Paul Leonard Weber, Konstantin Schürheck, Kim C Wagner, Nadine Köhler, Wolfgang Hiller, Karl J Oldhafer","doi":"10.1159/000541656","DOIUrl":"10.1159/000541656","url":null,"abstract":"<p><strong>Introduction: </strong>Ambulatory surgeries are on the rise in recent years and can offer benefits to patients as well as healthcare providers. Laparoscopic cholecystectomy is one of the procedures commonly done in an ambulatory setting, in some European countries. This study aims to gather patients' perceptions towards ambulatory cholecystectomy after undergoing laparoscopic cholecystectomy in an inpatient setting.</p><p><strong>Methods: </strong>A total of 300 patients from two different hospitals in Germany received a postoperative questionnaire aimed at evaluating their willingness to undergo an ambulatory surgery. Surgeries were performed between January 1, 2017, and July 11, 2018. Operation setting (acute vs. elective), ASA classification, length of hospital stay, age, sex, living situation and location (city vs. rural), as well as status of employment were documented.</p><p><strong>Results: </strong>Overall, 23% of patients reported considering ambulatory laparoscopic cholecystectomy (ALC), while 77% rejected an ALC. Objections included fear of complications (69%), anticipated pain (65%), concerns about their living situation/home care (21%), other reasons (8%), nausea and vomiting (3.4%). Baseline characteristics of the participants provided no statistical significance on willingness to undergo ALC: acute versus elective (<i>p</i> = 0.22), ASA classification (<i>p</i> = 0.77), age ≥65 years versus <65 years (<i>p</i> = 0.60), gender (<i>p</i> = 0.07), living situation (<i>p</i> = 0.49), location (<i>p</i> = 0.15).</p><p><strong>Conclusion: </strong>There is a willingness for ALC, albeit still limited. Chosen criteria did not show a significant association for positive perception of ALC.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":"41 1","pages":"14-20"},"PeriodicalIF":1.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11801849/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
State-of-the-Art Surgery in Achalasia. 最先进的失弛缓症手术。
IF 1.6 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-12-01 Epub Date: 2024-10-30 DOI: 10.1159/000541928
Patrick S Plum, Stefan Niebisch, Ines Gockel

Background: Achalasia is a motility disorder of the esophagus and depending on its type, esophageal tubular hypo- or hypermotility can cause typical symptoms, such as dysphagia, chest pain, weight loss, or regurgitation. Clinical symptoms during initial diagnosis as well as over the course of therapy can be measured by the Eckardt score. Diagnostics include high-resolution manometry (HR manometry), (timed barium) esophagogram, upper gastrointestinal endoscopy, multiple rapid swallow response, and Endo-FLIP measurement. In this work, we provide a review of the recent literature on surgical treatment of achalasia.

Summary: Besides pharmacological and endoscopic interventions, surgical procedures of laparoscopic/robotic Heller myotomy (LHM/RHM) and 180° anterior Dor's semifundoplication versus 270° dorsal Toupet's fundoplication are primary therapeutic options, especially for type I and II achalasia. Both surgical procedures display little morbidity and mortality. Postsurgical results are comparable between LHM and RHM. RHM allows better angulation during myotomy, lower rates of intraoperative mucosal laceration, and better visualization of the muscles in the lower esophageal sphincter area. Surgery can also be performed safely after failed endoscopic treatments.

Key messages: Surgery in achalasia is especially indicated in patients ≤40 years and also recommended after repeated unsuccessful or complicated endoscopic interventions. In selected patients with end-stage achalasia and sigmoid-shaped megaesophagus, esophagectomy is a reasonable option in order to improve quality of life.

背景:贲门失弛缓症是一种食道运动性疾病,根据食道的类型,食道小管运动性低或高可引起典型症状,如吞咽困难、胸痛、体重减轻或反流。临床症状在最初的诊断以及整个治疗过程中可以通过Eckardt评分来衡量。诊断包括高分辨率测压(HR测压)、(定时钡)食管造影、上消化道内窥镜、多次快速吞咽反应和Endo-FLIP测量。在这项工作中,我们提供了最近的文献综述手术治疗贲门失弛缓症。总结:除了药物和内窥镜干预外,腹腔镜/机器人Heller肌切开术(LHM/RHM)和180°Dor前半底折叠与270°背Toupet底折叠是主要的治疗选择,特别是对于I型和II型贲门失弛缓症。这两种手术的发病率和死亡率都很低。术后结果在LHM和RHM之间具有可比性。RHM可以在肌切开术中更好地成角,降低术中粘膜撕裂率,更好地显示食管下括约肌区域的肌肉。内窥镜治疗失败后也可以安全地进行手术。关键信息:贲门失弛缓症特别适用于年龄≤40岁的患者,也推荐在多次不成功或复杂的内镜干预后进行手术。在选定的终末期贲门失弛缓症和乙状状肥大食管患者中,食管切除术是一种合理的选择,以提高生活质量。
{"title":"State-of-the-Art Surgery in Achalasia.","authors":"Patrick S Plum, Stefan Niebisch, Ines Gockel","doi":"10.1159/000541928","DOIUrl":"10.1159/000541928","url":null,"abstract":"<p><strong>Background: </strong>Achalasia is a motility disorder of the esophagus and depending on its type, esophageal tubular hypo- or hypermotility can cause typical symptoms, such as dysphagia, chest pain, weight loss, or regurgitation. Clinical symptoms during initial diagnosis as well as over the course of therapy can be measured by the Eckardt score. Diagnostics include high-resolution manometry (HR manometry), (timed barium) esophagogram, upper gastrointestinal endoscopy, multiple rapid swallow response, and Endo-FLIP measurement. In this work, we provide a review of the recent literature on surgical treatment of achalasia.</p><p><strong>Summary: </strong>Besides pharmacological and endoscopic interventions, surgical procedures of laparoscopic/robotic Heller myotomy (LHM/RHM) and 180° anterior Dor's semifundoplication versus 270° dorsal Toupet's fundoplication are primary therapeutic options, especially for type I and II achalasia. Both surgical procedures display little morbidity and mortality. Postsurgical results are comparable between LHM and RHM. RHM allows better angulation during myotomy, lower rates of intraoperative mucosal laceration, and better visualization of the muscles in the lower esophageal sphincter area. Surgery can also be performed safely after failed endoscopic treatments.</p><p><strong>Key messages: </strong>Surgery in achalasia is especially indicated in patients ≤40 years and also recommended after repeated unsuccessful or complicated endoscopic interventions. In selected patients with end-stage achalasia and sigmoid-shaped megaesophagus, esophagectomy is a reasonable option in order to improve quality of life.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":"40 6","pages":"293-298"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11631102/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Visceral Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1